Movement Disorders

Papers
(The H4-Index of Movement Disorders is 45. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Prevalence of NOTCH2NLC and FMR1 Repeat Expansions in Atypical Parkinsonism Compared to Asymptomatic Elderly Individuals588
The FDA Has Ended Required Blood Monitoring for Clozapine Use—Will This Impact the Management of Parkinson's Disease Psychosis?231
Dual Task Turning in Place: A Reliable, Valid, and Responsive Outcome Measure of Freezing of Gait180
Adaptive Deep Brain Stimulation: From Experimental Evidence Toward Practical Implementation138
Fixel‐Based Analysis Reveals Whole‐Brain White Matter Abnormalities in Cervical Dystonia120
Investigation of Shared Genetic Risk Factors Between Parkinson's Disease and Cancers105
Annonaceae Consumption Worsens Disease Severity and Cognitive Deficits in Degenerative Parkinsonism99
May Infographic94
Deep Brain Stimulation of the Globus Pallidus Internus and Externus in Multiple System Atrophy90
In Memoriam Mahlon R. DeLong (1938–2024)90
Early Changes in Striatal Activity and Motor Kinematics in a Huntington's Disease Mouse Model89
83
Treatment for Dyskinesia in Parkinson's Disease: A Network Meta‐analysis of Randomized Controlled Trials78
The Emergence and Progression of Motor Dysfunction in Individuals at Risk of Parkinson's Disease78
Movement Disorders: Volume 40, Number 6, June 202577
Motor Cortex Disinhibition Correlates with Olfactory Dysfunction in Parkinson's Disease74
Movement Disorders: Volume 40, Number 2, February 202573
Bidirectional Transcription at the PPP2R2B Gene Locus in Spinocerebellar Ataxia Type 1267
John Michael Walshe (April 24, 1920–October 14, 2022)66
Stability of Mosaic Divergent Repeat Interruptions in X‐Linked Dystonia‐Parkinsonism66
Issue Information66
The Hypoxia Response Pathway: A Potential Intervention Target in Parkinson's Disease?65
The Pattern and Stages of Atrophy in Spinocerebellar Ataxia Type 2: Volumetrics from ENIGMA‐Ataxia62
Substantia Nigra Elasticity Measurement Using Transcranial Shear Wave Elastography: A Potential Biomarker for Parkinson's Disease62
Classifying Idiopathic Rapid Eye Movement Sleep Behavior Disorder, Controls, and Mild Parkinson's Disease Using Gait Parameters59
The Views of Patients with Isolated Rapid Eye Movement Sleep Behavior Disorder on Risk Disclosure59
Plasma Biomarkers and Positron Emission Tomography Tau Pathology in Progressive Supranuclear Palsy58
Biallelic Variants in SLC27A3 Cause a Complex Form of Neurodegeneration with Brain Iron Accumulation57
α‐Synuclein V15A Variant in Familial Parkinson's Disease Exhibits a Weaker Lipid‐Binding Property56
A Double‐Blind, Randomized, Placebo‐Controlled Trial of Ursodeoxycholic Acid (UDCA) in Parkinson's Disease55
Reply to: “Early Indian Age at Onset of Parkinson's: A Case for a Gene‐Environment Lens”54
Re‐emergent Tremor in Parkinson's Disease: Evidence of Pathologic β and Prokinetic γ Activity53
Friedreich's Ataxia in Colombia: A Population‐Based Study of Incidence and Socioeconomic Determinants53
A CGG Repeat Expansion in CSNK1E Associated with Progressive Myoclonic Epilepsy with Incomplete Penetrance50
Neurodevelopmental Disorder and Cortical Myoclonus in ZMYM2 Deficiency50
Compound Heterozygous Structural Variants in Cases with Unsolved PRKN‐Associated Parkinson's Disease50
Dystonia49
AI, Technology, Telemedicine49
Author Index48
Patients with Allan‐Herndon‐Dudley Syndrome (MCT8 Deficiency) Display Symptoms of Parkinsonism in Childhood and Respond to Levodopa/Carbidopa Treatment47
Functional Movement Disorders and Drug‐Induced Movement Disorders47
Cortical Functional Connectivity Changes in the Body‐First and Brain‐First Subtypes of Parkinson's Disease47
Diagnostic and Prognostic Value of External Anal Sphincter EMG Patterns in Multiple System Atrophy46
Stress in Musicians with and Without Focal Dystonia Is Not Reflected in Limbic Circuit Activation46
Central Involvement in Pure Autonomic Failure: Insights from Neuromelanin‐Sensitive Magnetic Resonance Imaging and 18F‐Fluorodopa‐Positron Emission Tomography46
45
0.0837721824646